Thanks Erbb - very interesting numbers.
2 guest doctors and out pops a number from Steven Garner that I was not familiar with, "there are 100 Million people living with intractable pain". He also said that Tylenol is a major cause of liver damage when combined with other pain drugs which is common.
If correct, I'm even more comfortable with the future of BIEL.
If BIEL and any other device firms operating outside of BIEL's IP patent can help Americans in significant numbers manage their intractable pain, the market is profitable.
Question might be, what might a significant number be? I would say that 2% (2 Million) is a small number; 10% (10 Million) might be a number that could be expected; and 25% (25 Million) would be a "significant" number of existing potential users of pain management devices. These are people already suffering from difficult to deal with pain issues. Now add in those Americans dealing with pain that is easier to deal with, how many of them are there? Are we a nation in pain? No small wonder the experts are concerned about physical conditioning, obesity and working out, even walking twice a week! What a great market.
I'm not experienced enough at pharma sales numbers to know where to go now. Significant portion of the 100 Million number plus a portion of other Americans with more easily managed pain, plus those with irregular pain, plus women who might use ALLAY and you have a number. Figure out need, usage and battery life and frequency and we have units. Times dollars and we have a sales estimate. Times a multiple and we have a value of device companies and BIEL is right in the middle of that space with multi patented products in its pain management line. Where is our buddy ImRich when we need him, he's good at this stuff along with other good guys here. I'll leave it to other posters to comment on Dr. Garner's numbers and help me with mine and estimate the annual market and dollar sales potential for BIEL. Thanks again Erbb
